The trademark application AGLASYNX was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on May 13, 2020, and it was registered by office on August 21, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 25, 2020.